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Abstract
Background: Studies of differential expression that use Affymetrix GeneChip arrays are often
carried out with a limited number of replicates. Reasons for this include financial considerations
and limits on the available amount of RNA for sample preparation. In addition, failed hybridizations
are not uncommon leading to a further reduction in the number of replicates available for analysis.
Most existing methods for studying differential expression rely on the availability of replicates and
the demand for alternative methods that require few or no replicates is high.
Results:  We describe a statistical procedure for performing differential expression analysis
without replicates. The procedure relies on a Bayesian integrated approach (BGX) to the analysis
of Affymetrix GeneChips. The BGX method estimates a posterior distribution of expression for
each gene and condition, from a simultaneous consideration of the available probe intensities
representing the gene in a condition. Importantly, posterior distributions of expression are
obtained regardless of the number of replicates available. We exploit these posterior distributions
to create ranked gene lists that take into account the estimated expression difference as well as its
associated uncertainty. We estimate the proportion of non-differentially expressed genes
empirically, allowing an informed choice of cut-off for the ranked gene list, adapting an approach
proposed by Efron. We assess the performance of the method, and compare it to those of other
methods, on publicly available spike-in data sets, as well as in a proper biological setting.
Conclusion: The method presented is a powerful tool for extracting information on differential
expression from GeneChip expression studies with limited or no replicates.
Background
Affymetrix GeneChips are one of the most widely used
commercially available oligonucleotide arrays. They have
gained widespread popularity for a number of reasons,
among which are their high degree of standardization of
the production process and their ability to interrogate tens
of thousands of genes simultaneously. They differ from
many other array types in that they are one color (and
sample) arrays and because each gene is represented by a
probe set of pairs of perfect match (PM) and mismatch
(MM) probes. Each PM is chosen to match a particular 25
base pair stretch of the sequence encoding the gene, and
the full set of PMs is chosen with the aim of uniquely
identifying the gene. The accompanying MMs are identi-
cal to their PM counterparts except for a complementary
base substitution at the middle nucleotide. They are
intended to be used to correct for non-specific hybridiza-
tion. The full set of PMs and MMs for a gene represent the
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basis for the estimation of the level of expression of the
gene.
Most GeneChip based expression studies are carried out
with few replicates. There are two major factors behind
this: the considerable cost of the GeneChip arrays and
limitations on the amount of available RNA. As micro-
array expression studies are prone to experimental imper-
fections, failed hybridizations are often encountered
resulting in further reduction in the number of replicates
available for analysis. If the number of replicates falls
below three, most available analysis tools become unsuit-
able or unapplicable because they rely on the estimation
of variances which is difficult in such circumstances. Thus,
the development of methods for analyzing experiments
with few or no replicates is of high importance.
Bayesian  Gene eXpression, BGX [1], is an integrated
approach to the analysis of Affymetrix GeneChip arrays. It
relies on the formulation of a Bayesian hierarchical model
for estimating expression levels from probe level Gene-
Chip data. In the BGX approach background correction,
gene expression level estimation and differential expres-
sion is performed in an integrated analysis, allowing all
uncertainties to be dealt with simultaneously in a coher-
ent statistical framework. Posterior distributions of gene
and condition specific BGX expression levels are obtained
from a simultaneous consideration of the probe pair
intensities in the available probe sets representing the
gene. Samples from the posterior distributions are gener-
ated using Markov chain Monte Carlo methods. If repli-
cate arrays are available the information in their probe set
intensities will be considered jointly in the estimation of
expression levels. Replicate arrays, however, are not essen-
tial for obtaining the posterior distributions of expression
for the genes – these will be obtained from the collection
of intensities on the array even when only a single array is
available. Samples from the posterior distribution of the
differences in expression levels present a basis for infer-
ence on differential expression.
In this paper we develop a method for performing differ-
ential expression studies from GeneChip experiments
without replicates. The procedure exploits the posterior
distributions of differences in expression, obtained from a
BGX analysis of GeneChip arrays, for creating ranked gene
lists. In order to define suitable cut-offs for the list, an esti-
mate of the proportion of differentially expressed genes is
obtained by empirically estimating the null distribution
of a relevant statistic using an approach similar to that of
Efron [2]. The performance of the method is tested on
publicly available spike-in data sets and compared to
those of other methods, and further evaluated in a biolog-
ical study.
Results and discussion
The BGX model and methodology
Most methods for analyzing GeneChip arrays adopt a
stepwise procedure for obtaining a point estimate of
expression for each gene on each array. The steps in the
procedures typically consist of background correction and
normalization followed by summarization (e.g. as in
MAS5 [3]) or the fitting of a linear model, often per-
formed on the log-scale background corrected intensities
(e.g. as in RMA [4]). Having obtained a point estimate of
expression for each gene on each array, studies of differen-
tial expression between pairs of conditions are carried out
by comparing the collections of point estimates under the
conditions using a t-type statistic such as in SAM [5],
Cyber-T [6] or Limma [7].
The BGX method differs from these stepwise point esti-
mate approaches in that (1) all steps in the analysis are
dealt with simultaneously, (2) gene and condition specific
expression levels are estimated from a joint consideration
of the available probe set intensities and (3) the outcomes
are posterior distributions of expression rather than point
estimates. Thus, uncertainties associated with each of the
steps are taken into account at all levels of analysis, and
the joint uncertainty on the expression level for a gene
under a condition is reflected in the shape of the posterior
distribution obtained for the level of expression for that
gene under that condition.
Explicitly, with g, j, c and r denoting gene, probe, condi-
tion and replicate, respectively, let Sgjcr and Hgjcr denote
gene, probe, condition and replicate specific and non-spe-
cific binding (relative to the PM probe) of RNA, and let φ
∈ (0,1) be a fraction. To further allow for additive array
specific errors, e.g. accommodating MMs bigger than PMs,
the BGX model hypothesizes:
PMgjcr ~ N(Sgjcr + Hgjcr, )
MMgjcr ~ N(φSgjcr + Hgjcr, ).    (1)
Information on the level of expression of gene g under
condition c is represented by the set of signal parameters
representing the gene under this condition: Sgjcr, j = 1,...,J,
r = 1,..., Rc. We assume that these, shifted and logged,
come from a gene and condition specific truncated nor-
mal distribution. The non-specific hybridization parame-
ters  Hgjcr  reflect characteristics specific to the sample
hybridized, leading us to assume array specific truncated
normal distributions for these, shifted and logged. Thus,
log(Sgjcr + 1) ~ TN(μgc, ),
τcr
2
τcr
2
σgc
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log(Hgjcr + 1) ~ TN(λcr, ).    (2)
We will here refer to the μgc parameters as the BGX expres-
sion indices or levels. We assume exchangeability of the
gene and condition specific variance parameters,
log( ) ~ N(ac, ),    (3)
with ac and   fixed at values obtained by an Empirical
Bayes like approach, thus stabilizing the variance estima-
tion. In all of the above, the distributions are conditional
on variables on the right hand side, and independent for
all suffices. The model is fully specified by declaring the
following, generally weakly informative priors, independ-
ent for all suffices: μgc ~ U(0, 15), φ ~ (1,  1),  λgc ~ N(0,
1000)),   ~  Γ(0.001, 0.001) and (ηgc
2)2 ~ Γ(0.001,
0.001)). For a more in-depth discussion of the model we
refer to [1].
The BGX model relies on MCMC methods for obtaining
samples from the posterior distributions of the parame-
ters. The shapes of the posterior distributions of the BGX
gene expression indices, μgc, are determined by the probe
response patterns (see [1]). Thus, a highly consistent
probe set response leads to a tight posterior distribution of
expression, and a less consistent pattern will result in a
flatter, possibly multi-modal, posterior distribution.
Examples of posterior expression index distributions, μg,1
and μg,2, are given in Figure 1 (upper panel).
The corresponding kernel density plots for the differences
in expression indices, dg = μg,1 - μg,2, are given in Figure 1
(lower panel). The uncertainties of the expression indices
are reflected in the shape of these distributions. For gene
11209 the multi-modality of the posterior distribution of
the expression index under condition 2 (μ11209,2) is reiter-
ated by the multi-modal posterior distribution of the dif-
ference in expression. For the other two example genes the
posterior distributions of the differences in expression are
tight and uni-modal, centered close to zero and around
one respectively, indicating similar expression levels for
gene 330 and different expression levels for gene 22 under
the two conditions considered.
Addressing differential expression with replicates
A popular approach to conducting differential gene
expression studies is to rank the genes according to their
degree of evidence for differential expression, and to esti-
mate false discovery rates for different cut-offs on the
ranked gene list. This allows the experimenter to obtain a
prioritized list of genes to pursue in follow-up studies,
with a guidance as to how many genes on the list are
expected to be false positives. Such approaches are taken
in the implementations of the SAM, Limma and Cyber-T
methods. Each of the methods calculate a different modi-
fied t-statistic, the modification relating to the standard
deviation or variance calculation in the denominator, and
genes are ranked on the resulting p-values. In SAM a false
discovery rate is estimated based on permuting the origi-
nal data to get the distribution of (modified) t-statistics
under the null-hypothesis of no differential expression.
Limma is implemented with the Benjamini and Hochberg
method [8] for estimating FDR and calculation of
adjusted p-values. Cyber-T adopts the method of Allison
et al. [9] for fitting a mixture of Beta-distributions (one of
which is the U(0,1) distribution) to the observed p-values,
and reports estimated true and false positives along with
the posterior probability of differential expression. Thus,
all methods make use of point estimates of expression and
depend upon replicates being available for estimation of
the variance in the modified t-statistics (and in SAM for
the permutation).
Addressing differential expression without replicates
Without replicates the above methods for analysis of dif-
ferential expression are unapplicable and alternative
methods are needed. In this section we describe how the
BGX model and methodology may be exploited to obtain
such a procedure. We use features of the samples from the
posterior distributions collected in the MCMC sampling
to produce ranked gene lists. The ranking takes into
account the estimated difference in expression level as well
as the associated uncertainty. We then consider the set of
posterior probabilities of expression differences being
smaller than zero, P(dg < 0), g = 1,..., G. By comparing their
observed distribution to that expected under the null-
hypothesis of no differential expression, we obtain an esti-
mate of the number of differentially expressed genes, GD.
This allows us to choose the cut-off of the ranked gene list
in an informed manner.
The procedures for ranking the genes and for estimating
GD in the BGX framework are described in two separate
subsections below. The final part of this section contains
a comparison of the performance of the BGX based
method for performing differential expression analysis
from GeneChips without replicates to those of other avail-
able methods: the EBarrays method of Kendziorski et al.
[10], the Wilcoxon signed rank test for comparison calls of
the MicroArraySuite software [3], and the Efron [2]
method using the standardized BGX differences (see
below) as z-statistics.
Ranking genes using BGX
In the BGX framework, the samples from the posterior
distributions of the differences dg = μg,1 - μg,2, g = 1,...,G,
ηcr
2
σgc
2 bc
2
bc
2

τgc
2 1 ()
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represent a natural base for inference on differential
expression between conditions 1 and 2. These are availa-
ble irrespectively of the number of replicates for each con-
dition used in the analysis. There are numerous ways in
which these posterior distributions can be exploited with
the aim of addressing expression differences. Here we
study two types of rankings reflecting the potential of the
genes as promising candidates for differential expression:
(1) ranking on the 'standardized BGX differences', zg =
mean(dg)/sd(dg), where the mean and standard deviation
are computed from the posterior sample of dg values, and
(2) ranking on the highest percentile, α*, for which the α-
percent credibility interval for the difference dg does not
cover zero. Note that both rankings use the levels of differ-
ential expression (the means or the locations of the poste-
rior distributions of the dgs) as well as the uncertainty of
these (the standard deviation of the posterior sample or
the width of the posterior distributions) in the ranking.
Without replicates point estimate based methods clearly
do not have this ability.
To illustrate ranking (2), consider the posterior distribu-
tions of expression index differences in Figure 1 (lower
panels). All sampled values from the posterior distribu-
tion of d22 are above zero and α* for gene 22 is indistin-
guishable from 100%. For gene 330, only very tight
credibility intervals exclude zero, and α* for this gene is
small (33%). For gene 11209, α* is around 75%.
Rankings of type (1) and (2) differ in their emphasis of
the posterior distribution characteristics: type (1) summa-
rizes the full distribution by a traditional t-type statistic
(calculated on the posterior sample) and we would expect
it to perform well when ranking Gaussian-shape posterior
dg distributions (as in Figure 1, genes 330 and 22) and
possibly less well in the presence of asymmetric or multi-
modal distributions (as in Figure 1, gene 11209). Type (2)
rankings use the tails of the posterior dg distributions and
should deal equally well with symmetric and asymmetric
distributions. However, we rely on a finite sample from
the MCMC procedure (we use a sample size of 1024) for
Posterior distributions of BGX expression levels and their differences Figure 1
Posterior distributions of BGX expression levels and their differences. Kernel density plots of samples of size 1024 
from the posterior distributions of the BGX expression indices, μg,1 (full line) and μg,2 (broken line) (upper panel), and their dif-
ferences, dg = μg,1 - μg,2 (lower panel), are shown for three genes under two conditions, each represented by a single array.
02468
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
gene 11209
expression levels
D
e
n
s
i
t
y
− 6 − 4 − 2 0246
0
.
0
0
0
.
0
5
0
.
1
0
0
.
1
5
0
.
2
0
gene 11209
difference in expression
D
e
n
s
i
t
y
2468
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0
gene 330
expression levels
D
e
n
s
i
t
y
−4 −2 0 2 4
0
.
0
0
.
1
0
.
2
0
.
3
0
.
4
0
.
5
0
.
6
gene 330
difference in expression
D
e
n
s
i
t
y
2468
0
.
0
0
.
5
1
.
0
1
.
5
2
.
0 gene 22
expression levels
D
e
n
s
i
t
y
−4 −2 0 2 4
0
.
0
0
.
4
0
.
8
1
.
2
gene 22
difference in expression
D
e
n
s
i
t
yBMC Bioinformatics 2006, 7:353 http://www.biomedcentral.com/1471-2105/7/353
Page 5 of 15
(page number not for citation purposes)
approximating the distributions, and the estimation of
the tails of the distributions may be fragile.
We examined the performance of the two ranking proce-
dures for the BGX method on the results from the nine
analyses of pairs of arrays from the Choe data set [11], that
consist of a condition C array and a condition S array. On
each pair of arrays we ran the BGX model with 2 condi-
tions and 1 replicate per condition, and obtained ranked
gene lists using each of the rankings (1) and (2). For the
Choe data it is known exactly which genes are differen-
tially expressed (there are 1331 differentially expressed
genes out of 14010). This allows the exact numbers of true
and false positives and negatives to be calculated, for all
possible cut-offs in ranks of the ranked gene lists. The two
rankings resulted in almost identical counts, and there is
no indication from this analysis that either is to be pre-
ferred. ROC curves summarizing the counts obtained with
ranking (1) are shown in Figure 2.
The performance of the BGX-based rankings from the sin-
gle replicate comparisons in the Choe data set is remarka-
ble: a quarter of the 1331 truly differentially expressed
genes are included in gene lists with realized false discov-
ery rates of 0.02 (gene list length approximately 500). By
extending the gene list to 700 genes (5% of the total
number) the proportion of truly differentially expressed
genes detected is increased to 50% and the realized false
discovery rate thus about 6%. Gene lists of lengths 1300
include 70% of the truly differentially expressed genes
and have observed false discovery rates of approximately
30%. Furthermore, the curves for the nine different analy-
ROC curves for one versus one comparisons of arrays from the Choe data set obtained with different methods Figure 2
ROC curves for one versus one comparisons of arrays from the Choe data set obtained with different meth-
ods. A curve is plotted for each pairwise comparison of a single C array to a single S array (9 grey lines) with the average curve 
superimposed (broken black). For BGX the curve obtained from an analysis that uses all three C replicate arrays against all 
three S replicate arrays is also shown (full black line). For BGX ranking (1) is used (see text). For MAS5 and RMA genes are 
ranked on their absolute value of difference in expression. The lower panels are blow-ups of the leftmost parts of the upper 
panels. TP: true positives, FP: false positives, TN: true negatives, FN: false negatives.BMC Bioinformatics 2006, 7:353 http://www.biomedcentral.com/1471-2105/7/353
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ses of pairs of arrays are highly similar, indicating a stable
performance. For comparison, ROC curves obtained for
the same pairwise analyses using MAS5 and RMA are also
given in Figure 2. For these analyses, genes were ranked on
the absolute values of the differences in expression meas-
ures (obtained with RMA or MAS5) between conditions.
With just one replicate array per condition, uncertainty of
the estimates of expression is not accounted for by these
methods, and they both do less well than the BGX-based
method. Due to the high variability of MAS5, this method
performs particularly poorly in the one-versus-one array
rankings.
To put the above performances into perspective the ROC
curve obtained for the same method of ranking but using
results from a BGX analysis that uses all the available
arrays (two conditions, three replicates each) are also
shown in Figure 2. For this analysis the number of truly
differentially expressed genes included in the lists are
increased by 25, 10 and 5% respectively to 50, 60 and
75% for the levels of realized false discovery rates of 0.02,
0.06 and 0.3. Thus, as expected, gene ranking is improved
when all replicates are used. However, the proportion of
the information contained in the full data set, that may be
extracted from the single replicate analyses array is consid-
erable. We note that the performance of the BGX multiple
array model on the full Choe data set is among the meth-
ods found to perform best (see [10], Figure 7). Results
from a similar analysis on the much less extensive
AffyU133A spike-in data set [12], are shown in Figure 3.
As only 42 of the 22300 genes represented in this data set
are differentially expressed, we plot absolute rather than
fractional values of true and false positives. For this data
set the ranking of the top genes produced by the three
methods are similar. For gene lists longer than 15, BGX
and RMA outperform MAS5, and RMA performs better
than BGX for lengths above 35. Thus, the relative perform-
ances of the methods differ for the Choe and the
AffyU133A data sets. This is most likely due to the differ-
ent levels of noise in the two data sets. With only 42 spike-
in genes in the AffyU133A data set arrays from two differ-
ent conditions are almost like technical replicates. In the
Choe data set, the 1331 genes spiked-in at varying concen-
trations at small to moderate fold changes result in a
noticeable, and more biologically realistic, level of noise
between the two conditions compared. Thus, for the Choe
data set, noise has an impact and accounting for this, as is
done with the BGX based ranking, is essential, whereas for
the AffyU133A data set, the impact of noise is negligible
and the importance of taking this into account is out-
weighed by that of reproducibility of point measures for
(almost) technically replicate arrays.
Estimation of the proportion of differentially expressed genes
Having obtained a ranked list of genes the next question
is whether we can choose a suitable cut-off. Depending on
the downstream goal, we may wish to arrive at a (long) list
that has a good chance of containing most or all of the
"interesting" genes (meaning those that are differentially
expressed), accepting that false positives will also be
included, or we may prefer to end up with a (short) list of
genes most of which would appear to be promising candi-
dates for differential expression, expecting very few false
positives to be included. To guide the choice of cut-off, it
is useful to obtain an estimate of the proportion of differ-
entially expressed genes. To do this, we estimate empiri-
cally the distribution of a relevant statistic under the null
hypothesis, which in turn allows for the quantification of
the proportion of non-null behaving genes, following the
idea of Efron [2].
We consider, for each gene g, the posterior distribution of
the difference in expression, dg = μg,1 - μg,2, obtained from
the BGX analysis. Under the null-hypothesis of no differ-
ential expression this posterior distribution should be
centered on zero. Rephrasing in terms of the posterior P(dg
< 0) probability, under the null we expect this to be 0.5.
Considering the posterior P(dg < 0) probabilities for the
full set of genes analyzed, under the null hypothesis of no
differential expression there should be decreasingly less
support for values away from 0.5 towards 0 and 1. Thus,
with no differentially expressed genes a histogram of the
P(dg < 0) probabilities should be uni-modal with mode of
approximately 0.5, and have smoothly decreasing tails.
The width of the central component of the histogram will
depend on the posterior distributions of the dg's: the less
clean the information on the expression levels (e.g. the
more noisy the data), the less tight the dg distributions,
and thus the flatter the histogram of P(dg < 0) values. (We
have phrased the above in terms of the P(dg < 0) values but
could of course equally well have phrased them in terms
of the P(dg > 0) values).
Deviations in a histogram of P(dg < 0) values from the
expected shape under the null hypothesis of no differen-
tial expression indicate the presence of differentially
expressed genes: excess of P(dg < 0) values near zero and
one indicate over-expressed and under-expressed genes in
condition 1 relative to condition 2, respectively. To quan-
tify the number of non-null genes, we adopt an approach
similar to that of Efron [2]. We fit a polynomial, f, to the
histogram counts by Poisson regression and use the cen-
tral part of the histogram to estimate the null component,
while excess area in the tails will represent differentially
expressed genes. To be precise, we use the following pro-
cedure (see Figure 4 for illustration): We identify the innerBMC Bioinformatics 2006, 7:353 http://www.biomedcentral.com/1471-2105/7/353
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global max and left and right most minima on the fitted
curve  f, and refer to the histogram categories of these
points as cmax,   and   respectively. We use the cen-
tral part of the histogram (that between categories 
and  ) to obtain the distribution of the P(dg < 0) values
under the null: we fit two new curves,   and  , to the
parts of the histogram left and right of category cmax,
respectively, using the same fitting procedure as for the
curve f but fixing the histogram counts of the outermost
categories c1 and cK to zero (with K  denoting the total
number of categories in the histogram), and giving zero
weight to categories c2,...,   and ,..,ck-1 respec-
tively. An estimate of the number of genes under the null
is obtained by summing the fitted values of the empirical
null distribution f0,
Denoting the total number of genes by G, the estimated
proportion of differentially expressed genes is
Estimated numbers of over- and under-expressed genes,
 and   (in condition 1 relative to 2), are obtained by
quantifying the excess genes in either tail of the histogram
relative to those expected under the null. Denoting the
histogram count in category ci by h(ci) we set
cL
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ROC curves for one versus one comparisons of arrays from the AffyU133A data set obtained with different methods Figure 3
ROC curves for one versus one comparisons of arrays from the AffyU133A data set obtained with different 
methods. (see legend of Figure2).
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We applied the above method to the BGX analyses of the
pairs ofarrays from the Choe and AffyU133A data sets. An
example of a histogram of P(dg < 0) values from a within
condition comparison of two arrays from the Choe data set
is given in Figure 4, upper panel. The full set of histograms
for within condition analyses of pairs of Choe arrays are
summarized in Figure 5, left, in terms of plots of the
curves, f, fitted to the histogram counts by Poisson regres-
sion. For within condition comparisons the arrays are rep-
licates, so there should be no differentially expressed
genes, and the plots indeed exhibit the shape expected
under the null hypothesis: they have a central mode near
0.5 and smoothly decreasing tails. They thus confirm our
expectations and indicate that the method works well
under the null. Figure 4, lower panel, and Figure 5, right
panel, display the equivalent plots for pairwise between
condition analyses of the Choe data set arrays. The histo-
grams for these analyses exhibit a clear deviation from the
shape expected under the null in terms of an excess of
small P(dg < 0) values near zero indicating the presence of
over-expressed genes. The right-hand tails of the histo-
grams decrease smoothly and there is no indication of
under-expressed genes. This is exactly the pattern that
should emerge for the Choe between condition compari-
sons: all differentially spiked-in genes have higher con-
centration under condition S (our condition 1) than
under condition C (our condition 2). The estimates of the
numbers of differentially expressed genes obtained for the
Choe data are summarized in Table 1. For the within-con-
dition analyses the estimates of the proportions of differ-
entially expressed genes are near zero, indicating high
specificity of the method. For the between condition anal-
yses, the number of differentially expressed genes is esti-
mated to be approximately 700. Of the genes declared
differentially expressed approximately 95% are true posi-
tives, demonstrating the methods high positive predictive
value.
A similar analysis on the AffyU133A data is summarized
in Figure 6, supplementary Figure 1 [see Additional file 1]
and Table 1. For this data set the histograms of the P(dg <
0) values obtained for the replicate array comparisons and
the between experiment comparisons are more similar.
With the very few spike-in genes, and thus little difference
between the within and between experiment analyses in
this data set, this is expected. Also note that the central
component is tighter for the AffyU133A data set than for
the Choe data set, reflecting the lower level of noise.
Focusing on the tails of the histograms for the analysis of
arrays from different experiments (right), there is a clear
deviation from the shape expected under the null, in
terms of an excess of P(dg < 0) values near 0 as well as 1,
indicating the presence of both over- and under-expressed
genes. The estimated numbers of differentially expressed
genes in the between experiment analyses are around 30,
and only a couple for the within experiment analyses. Of
the genes declared differentially expressed in the between
condition comparisons approximately half are true posi-
tives. Thus, in spite of the relatively low fold changes of 2
in this data set, the method retains good sensitivity and
high specificity.
Comparison to other methods
Few methods are available for performing differential
expression analysis from GeneChip arrays in the absence
of replicates. Here we compare the performance of the
BGX based method to those of three other methods that
may be applied when only a single replicate is available:
the EBarrays method of Kendziorski et al. [10] and the
Affymetrix MAS comparison calls [3]. The MAS compari-
son calls are based on the Wilcoxon signed rank test
applied, for each gene, to the sets of PM-MM values on the
two arrays to be compared. The Wilcoxon signed rank test
is available in R. We rank the genes on their p-values and
use as cut-off the recommended value of 0.0025 to declare
the genes as differentially expressed ([3]). The EBarrays
method (available from Bioconductor, [13]) implements
the empirical Bayes Gamma-Gamma or lognormal-nor-
mal mixture models, originally developed for two-colour
cDNA arrays, but equally applicable to analysis of differ-
ential expression between GeneChip arrays. We use the
lognormal-normal model, as generally recommended for
GeneChip data, and apply the method to both the RMA
expression values (transformed to the original scale) and
the MAS5 values. The method estimates the proportion of
non differentially expressed genes, p0, and for each gene,
their posterior probability of belonging to the non-null
component. We rank the genes following decreasing val-
ues of this probability and compute the rank cut-off by
multiplying p0 by the total number of genes analysed. As
an additional comparison, we show results for the Efron
(2004) method applied to the standardised BGX differ-
ences zg = mean(dg)/sd(dg), g = 1,...,G.
The method fits a spline to histogram counts of the zg val-
ues, using Poisson regression. The null distribution is then
empirically estimated from the observed distribution by a
first and second moment fitting of a normal distribution
to the central component, and used to produce an esti-
mate of p0. The genes are ranked on their absolute zg val-
ues and a rank cut-off is estimated as for the EBarrays
method above. Estimated numbers of differentially
expressed genes obtained with the various methods are
given in Table 1, along with numbers and proportions of
true positives among those declared differentially
expressed. The specificity and positive predictive value is
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Example histograms of the sets of P(dg < 0) values for within and between condition single replicate comparisons – Choe data  set Figure 4
Example histograms of the sets of P(dg < 0) values for within and between condition single replicate compari-
sons – Choe data set. Results shown are for analyses of condition C replicate 1 against condition C replicate 2 (upper panel) 
and condition C replicate 1 against condition S replicate 2 (lower panel). Grey curve: f, black curve: f0, grey circles: local 
maxima, grey triangles:   and  , black point in grey circle:   (see text). DEG: estimated number of differentially 
expressed genes,  ."weights": a 0 indicates that the category is given zero weight when fitting f0. "counts": a 0 indicates that 
the category is fixed to have count zero when fitting f0. "up" and "down" denote the estimated number of over- and under 
expressed genes,   and  . The upper histogram exhibits the shape expected under the null-hypothesis of no differentially 
expressed genes (the grey and black curves overlap), the lower indicates the presence of a subset of over-expressed genes.
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highest for the BGX based method. Among the other
methods, the EBarrays method with RMA expression
measures performs best. At the opposite extreme is the
EBarrays method with MAS5 expression values: this com-
bination results in very poor specificity and lowest posi-
tive predictive value of the methods tried. The poor
performance is likely to be caused by the high variability
and strong mean variance relationship of the MAS5 meas-
ure, which in combination with the assumption of a com-
mon variance for the genes and constant coefficient of
variation of the EBarrays model is detrimental. In con-
trast, the RMA method has low, stable, variance across the
genes, and thus conforms well to the assumptions of the
EBarrays method. Efron's method applied to the standard-
ised BGX differences has relatively high positive predictive
value (between that of the BGX method and the EBarrays
Plots of the curves (f, see text) fitted to the histogram counts of P(dg < 0) values for pairwise within and between condition  comparisons – Choe Data set Figure 5
Plots of the curves (f, see text) fitted to the histogram counts of P(dg < 0) values for pairwise within and 
between condition comparisons – Choe Data set. A curve is plotted for each pair of arrays in the Choe data set (left: 
within condition comparisons, right: between condition comparisons). The plots show the expected shape of uni-modality and 
smoothly decreasing tails under the null (left) and deviations from this pattern, largely in terms of an excess of over-expressed 
genes in the right-hand tails, for the between condition comparisons (right).
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with RMA). However, as seen in the large number of
wrongly declared differentially expressed genes in the
within condition comparisons, this is achieved at the
expense of high numbers of false positives. This shows
that the approximation of the null component of the his-
togram of standardised BGX differences by a Gaussian dis-
tribution in the Efron method is not entirely appropriate
and that a more flexible, non-parametric fit is indeed
needed. Finally, the performance of the Wilcoxon signed
rank test is relatively poor on both positive predictive
value and specificity.
A biological example
The applications of the method on the spike-in data set
analyses illustrate the performance of the method for
detecting and estimating the proportion of genes that
have been spiked into a common pool of RNA at different
concentrations. This is a somewhat stylized situation and,
in practice, what we are interested in is the performance of
the proposed method in analyses of realistic biological
data sets.
The virtue of the spike-in data sets is that we know exactly
which genes are differentially expressed. The problem
with testing the method on a biological data set is that
there are no biological data sets which possess this feature.
In the absence of such a data set we consider instead a bio-
logical data set for which we will regard part of the truth
as known: the Lin data set [14]. Lin et al. conducted a time
course experiment on mice, with the aim of identifying
hair cycle-associated genes. In mice, the first two hair
growth cycles are synchronous, but after these, hair
growth proceeds asynchronously. In the Lin et al. study,
the expression of genes in mouse back skin was measured
at 5 time points taken during the first hair-growth cycle
and at three time points after the second hair-growth
cycle. The authors hypothesized that genes related to hair-
growth cycle should exhibit increased replicate variance
from the synchronous to the asynchronous phase, and
identified 2289 genes for which the replicate variance was
significantly increased. To validate their findings they
went through a literature search and compiled a list of 89
genes that have been shown to be hair cycle-dependent by
using other methods (e.g. RT-PCR). Of the compiled list
of 89 genes, 72 were among the 2289 identified by Lin et
al's increased replicate variance based method on the
GeneChip data, thus verifying that hair-cycle associated
genes were found by their method. The time-course pro-
files of the 2289 genes were subsequently clustered, the
clusters studied and found to relate to distinct genetic
pathways.
We will use the literature-based compiled list of 89 hair
cycle-associated genes as a starting point for making a list
of what we will assume to be a subset of the list of "truly
differentially expressed genes" between two select time
points in the Lin data set. Note that a hair-cycle associated
gene need not be differentially expressed at any pair of the
time points studied. An examination of the time course
cluster profiles indicates that a sizeable subset of the hair-
Table 1: estimated numbers of differentially expressed genes. Estimated numbers of differentially expressed genes (numberDEG) for 
between (left part of table) and within (right part of table) condition analyses. For the between condition analyses the numbers of true 
positives (number TP) and proportions of true positives among those declared differentially expressed (proportion TP among DE) are 
also given (middle part of table). The upper part of the table shows result for the Choe data set, the lower for that of the Affy data set. 
Each row gives results for a particular method on the given data set. Shown are, for each data set and method the mean (in bold) and 
the minimum and maximum values (in parentheses) obtained over all the analyses of pairs of arrays performed. The BGX method has 
the highest positive predictive value and sensitivity.
between within
number DEG number TP proportion TP among DE number DEG
Choe data set:
BGX (P(dg < 0)) 705 (507,882) 674 (499,826) 0.961 (0.937,0.984) 4 (0,8)
BGX (Efron z-stat) 1161 (786,1448) 862 (738,949) 0.757 (0.647,0.939) 512 (185,830)
EBarrays(RMA) 773 (519,1006) 570 (448,686) 0.754 (0.574,0.863) 13 (0,80)
EBarrays(MAS5) 347 (240,443) 2 (1,4) 0.008 (0.002,0.013) 742 (266,1141)
Wilcoxon 2940 (2827,3019) 806 (755,840) 0.274 (0.267,0.278) 53 (29,242)
Affy data set:
BGX (P(dg < 0)) 28 (4,57) 13 (6,25) 0.510 (0.333,0.800) 2 (0,14)
BGX (Efron z-stat) 574 (318,894) 26 (23,28) 0.041 (0.029,0.075) 736 (365, 942)
EBarrays(RMA) 69 (40,100) 28 (19,35) 0.423 (0.310,0.542) 7 (0,22)
EBarrays(MAS5) 2831 (2610,3134) 12 (5,20) 0.004 (0.002,0.007) 2888 (2592,3115)
Wilcoxon 114 (75,167) 4 (3,6) 0.031 (0.018,0.057) 102 (71,186)BMC Bioinformatics 2006, 7:353 http://www.biomedcentral.com/1471-2105/7/353
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cycle associated genes may have different expression levels
at time points 14d and 23d (both within the first hair-
cycle), and we choose to consider arrays from these two
time points. Of the 89 genes in the literature compiled list,
only the 72, that were included in the list of the 2289
genes were clustered, and we thus only have information
on the expression levels at the two considered time points
for these 72 genes. The cluster membership of the 72
genes suggest that 11 belong to clusters with similar levels
of expression at time points 14d and 23d. Thus, we are left
with a list of 61 genes, from the initial list of 89, that: (1)
have been shown to be hair-cycle associated with other
methods such as RT-PCR, and that, (2) we would expect
to have different levels of expression at time points 14d
and 23d (as judged from inspection of the clusters to
which they belong). Importantly, there may well be many
other genes on the arrays, apart from those associated to
the hair growth cycle associated genes, that are differen-
tially expressed at the two time points considered. Thus
our assumption is that the list of 61 is a subset of the list (of
unknown length) of "truly differentially expressed genes at the
two time points". We take as a criterion for success the abil-
ity of the method to detect as differentially expressed these
61 genes – allowing that more genes than 61 may well be
differentially expressed.
Figure 7, left, shows a histogram of the P(dg < 0) values for
the analysis of the two arrays that measure the expression
levels in mouse 1 at the time points 14d and 23d. As
expected, the central mode of the histogram is considera-
bly wider than those for the Choe and AffyU133A data
sets, reflecting the larger levels of noise in this truly bio-
logical sample comparison. In spite of this, an excess of
genes in both tails of the histogram is clearly visible and
Example histograms of the sets of P(dg < 0) values for within and between condition single replicate comparisons – AffyU133A  data set Figure 6
Example histograms of the sets of P(dg < 0) values for within and between condition single replicate compari-
sons – AffyU133A data set. Results shown are for analyses of two arrays from the same experiment (Experiment 3, repli-
cates 1 and 2, left) and two arrays from different experiments (replicate 1 from Experiment 3 and 4, right). Lower panels are 
blow-ups of the lower part of the upper panels. Notation is as in Figure 4. The histogram on the left exhibits the shape 
expected under the null-hypothesis of no differentially expressed genes (the grey and black curves overlap), that to the right 
indicates the presence of small subsets of over- and under-expressed genes.
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we arrive at estimates of approximately 650 over-
expressed and 420 under expressed genes or approxi-
mately 7.5%. An examination of the identity of the top
1000 genes reveal that they include 42 of the 61 genes
from our assumed sublist of "truly differentially expressed
genes". Of the 42, 38 are ranked in the top 500. Thus, a
large proportion of the "known" truly differentially
expressed genes are thus found by the differential expres-
sion analysis with just a single replicate for each condi-
tion. As a further examination of the performance of our
method, we analyzed all the available arrays in the Lin
data set at time points 14d and 23d, using the BGX model
with two conditions of three replicates each. Figure 7,
right, shows the histogram of P(dg < 0) values for this anal-
ysis. The central component of the histogram of P(dg < 0)
values is much flatter for this analysis than for the one
mouse at time points 14d and 23d analysis. This is
expected: the histograms to the left relate to a comparison
of expression levels at two time points for the same mouse,
where as the histograms to the right are for a comparison
of expression levels at two time points between three sets
of mice. Although the three mice studied at the two time
Histograms of the P(dg < 0) values – Lin data set Figure 7
Histograms of the P(dg < 0) values – Lin data set. Results shown are for the two arrays from mouse 1 at time points 14d 
and 23d (left) and from mice 1, 2 and 3 at time points 14d and 23d (right). Both analyses show an excess of P(dg < 0) values in 
the tails indicating the presence of both over- and under expressed genes.
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points are the same, this is not taken into account in the
analysis, and the comparison is merely of average time-
point effects. Thus the dg distributions in the three against
three mice analysis include variability among mice within
each time point. Nevertheless, there is still a clear indica-
tion from the histogram of an excess number of over- as
well as under expressed genes, the number estimated to be
approximately 2130 (15% of the genes monitored).
Examining the identity of the genes we find that the 2000
highest ranked genes include the 42 genes from the list of
61 found in the without replicates analysis of the arrays
for mouse 1 (39 of these are in the top 500), and an addi-
tional 4. We take this as a further validation of the proce-
dure's ability to extract valuable information on
differential expression from GeneChip analysis in biolog-
ical studies without replicates.
Conclusion
We described a method for performing differential expres-
sion analysis from GeneChip arrays which does not
require replicates. In the method the posterior distribu-
tions of the expression differences are used to obtain
ranked gene lists and to estimate the proportion of differ-
entially expressed genes. We investigated the performance
of the method for analysis of one single array against
another and found the method to perform well on con-
trolled data sets as well as in a biological setting. The
method is not limited to analysis of one single array
against another, but is indeed applicable to analyses of
any one number of replicates against any other number.
The method for estimating the proportion of differentially
expressed genes relies on the empirical estimation of the
null distribution of the P(dg < 0) values. For this, we mod-
ified the method of Efron [2] in two ways. Efron's method
operates on standardised differences and fits a normal to
the central part of the observed distribution of these val-
ues. We found that the normal assumption for the null
component of the standardised BGX differences did not
produce convincing results. Instead, we chose to use the
natural quantity: P(dg < 0) that compares the expression
difference to its value under the null, and to exploit its
expected shape under the null. The values of P(dg < 0) are
bounded by 0 and 1, and there is no reason to expect that
the symmetric smoothly central component of their distri-
bution should follow any particular parametric shape. Fit-
ting a mixture of normal distributions with a variable
number of components as in Richardson and Green [15]
results in the central (that is, null) component being fitted
by a number of normals with means near 0.5, and differ-
ent variances. This makes characterising which compo-
nents of the mixture make up the null difficult. In the
procedure that we describe we have opted instead for sim-
plicity and attempting to stay close to the empirical distri-
bution by using a spline fit, rather than fitting a particular
parametric form.
A different approach to differential expression analysis in
the BGX framework would be add an additional hierarchi-
cal level to our BGX model and to define a mixture prior
for the expression levels rather than a flat prior. This
approach has be taken by a number of authors, for exam-
ple Kendiorski et al. [10] and Gottardo et al. [16], working
from (summary) expression level data, rather than probe
level intensities. Such an extended BGX model would be
statistically and theoretically appealing, but also compu-
tationally demanding, and will be explored in future
work.
Methods
Data sets
We use arrays from three data sets: the Choe data set, the
AffyU133A data set and the Lin data set. The data sets are
described below:
The Choe data set
We use the full Choe data set [10] which is a spike-in
study, consisting of 6 arrays, representing two conditions,
each with three replicates. The arrays are Drosgenomel
GeneChips with 14010 probe sets. The samples hybrid-
ized to the arrays consist of mRNA for 3860 genes at
known concentrations, with 1331 of the 3860 genes hav-
ing different concentrations under the two conditions.
Fold changes range from 1.2 to 4, and, when different,
concentrations are highest on condition S arrays. Thus of
the 14010 genes represented on the arrays, 10150 should
not be expressed, 3860 should be expressed, and 1331 of
the 3860 expressed genes should be differentially
expressed under the two conditions. The Choe data set
represents more realistic levels of between-condition
noise than most other available spike-in data set, because
the proportion of genes with differing concentrations is
substantial (approximately 10%). As for other spike-in
data sets, the within condition noise is low due to the
material on the arrays being technically replicate. For the
Choe data set there are 9 between condition analyses of a
single C to a single S array, and 6 within condition analy-
ses of either two condition C or two condition S arrays.
Because all genes are spiked up in concentration on the S
arrays relative to the C arrays in this data set particular care
must be taken in the normalization. In these analyses we
have replaced the normalization employed by default by
each of the methods by the following normalizations: for
the BGX, RMA and MAS5 methods, expression measures
were first calculated without normalization. The obtained
expression levels were subsequently normalized using a
flexible loess (span 0.1) normalization calculated from
the subset of non changing genes only. For the WilcoxonPublish with BioMed Central    and   every 
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signed rank analysis which is carried out at the probe
level, the MAS5 trimmed mean scaling was employed,
using the probes for the non-differentially expressed genes
only.
The AffyU133A data set
We use replicates 1 and 2 from each of the 14 experiments
in the Affymetrix Latin Square data set [12]. All arrays in
this experiment have technically replicate samples of RNA
hybridized, except for the spiking-in material of 42 genes
at known concentrations, differing between experiments.
We analyze the pairs of replicates for each experiment, k =
1,...,13, as well as the pairs of arrays from subsequently
numbered experiments, k and k + 1, for k = 1,...,13. The
fold changes in the spike-in concentrations in these
between experiment comparisons are 2 for 39 of the 42
genes, and ∞ for the remaining 3. As the AffyU133A arrays
have 22300 probe sets, a very small proportion is differen-
tially expressed (42/22300, or 0.5 %). Due to the techni-
cally replicate material used for all arrays, and the low
number of spike-in genes there should be very little noise
between as well as within conditions for this data set.
The Lin data set
Lin et al [14] conducted a time course experiment on
mice, with the aim of identifying hair cycle-associated
genes, using MGU74Av2 GeneChips. These arrays contain
14010 genes. We use two arrays from mouse 1 for time
points 14d and 23d (arrays GSM34315 and GSM34322)
for analysis without replicates. All six mouse arrays at the
two time points 14d and 23d are used in the two condi-
tions with three replicates each analysis.
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